NTR

Nutrien Ltd

Add to Watchlist

Advanced Chart

57.950

-1.18(-1.996%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

59.500

Open

58.600

VWAP

58.44

Vol

3.04M

Mkt Cap

28.31B

Low

57.950

Amount

177.48M

EV/EBITDA(TTM)

8.41

Total Shares

494.63M

42.72B

EV/OCF(TTM)

14.53

P/S(TTM)

1.13

Nutrien Ltd. is a global provider of crop inputs and services. The Company operates a network of production, distribution and ag retail facilities. The Company’s segments include Nutrien Ag Solutions (Retail), Potash, Nitrogen and Phosphate. Its downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. The Retail segment also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, South America and Australia. Its upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of its products.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

5.16B

+6.03%

0.697

+124.83%

5.32B

+4.61%

0.721

+84.77%

10.41B

+4.95%

2.393

+2.26%

Estimates Revision

The market is revising Upward the revenue expectations for Nutrien Ltd. (NTR) for FY2025, with the revenue forecasts being adjusted by 4.22% over the past three months. During the same period, the stock price has changed by 2.62%.

Revenue Estimates for FY2025

Revise Upward

+4.22%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+7.04%

In Past 3 Month

Stock Price

Go Up

+2.62%

In Past 3 Month

15 Analyst Rating

11.80% Upside

Wall Street analysts forecast NTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NTR is 64.79 USD with a low forecast of 56.00 USD and a high forecast of 75.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

9 Hold

0 Sell

Moderate Buy

11.80% Upside

Current: 57.950

Low

56.00

Averages

64.79

High

75.00

11.80% Upside

Current: 57.950

Low

56.00

Averages

64.79

High

75.00

TD Securities

NULL -> Buy

maintain

$67 -> $70

2025-08-01

Reason

TD Securities

Price Target

$67 -> $70

2025-08-01

maintain

NULL -> Buy

Reason

TD Securities raised the firm's price target on Nutrien to C$70 from C$67 and keeps a Buy rating on the shares.

UBS

Neutral

maintain

$56 -> $64

2025-07-23

Reason

UBS

Price Target

$56 -> $64

2025-07-23

maintain

Neutral

Reason

UBS raised the firm's price target on Nutrien to $64 from $56 and keeps a Neutral rating on the shares. The firm continues to expect medium-term declines across NPK pricing, the analyst tells investors in a research note.

Wells Fargo

Richard Garchitorena

Equal Weight

maintain

$59 -> $62

2025-07-17

Reason

Wells Fargo

Richard Garchitorena

Price Target

$59 -> $62

2025-07-17

maintain

Equal Weight

Reason

Wells Fargo analyst Richard Garchitorena raised the firm's price target on Nutrien to $62 from $59 and keeps an Equal Weight rating on the shares. The firm expects Q2 results and the outlook commentary to be generally positive. However, given the strong rally year-to-date, Wells remains selective in the space.

Oppenheimer

Outperform

maintain

$63 -> $65

2025-07-15

Reason

Oppenheimer

Price Target

$63 -> $65

2025-07-15

maintain

Outperform

Reason

Oppenheimer raised the firm's price target on Nutrien to $65 from $63 and keeps an Outperform rating on the shares. Coming into Q2 results, the firm notes a shift in investor sentiment, with the key debate in the agriculture space whether the reversion trade has run its course. Mixed with seasonal commodity weakness, Oppenheimer sees this now divided sentiment providing a difficult set-up into Q2 earnings season. The firm believes inputs have the opportunity to surprise to the upside, even against elevated expectations.

RBC Capital

Outperform

maintain

$65 -> $70

2025-07-14

Reason

RBC Capital

Price Target

$65 -> $70

2025-07-14

maintain

Outperform

Reason

RBC Capital raised the firm's price target on Nutrien to $70 from $65 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 results among Fertilizer names. Fertilizer prices performed better than expected through Q2: nitrogen on geopolitical turmoil resulting in supply outages and higher international natural gas prices, phosphate on continued supply tightness, and potash on continued strong demand, the analyst tells investors in a research note. Fertilizer equities continue to be a good defensive materials sector against broader market volatility, with limited tariff impacts, generally benefiting from geopolitical uncertainties, and likely seeing better than expected prices through the seasonal mid-year lull, RBC adds.

Jefferies

Laurence Alexander

Buy

Hold

downgrade

$63 -> $66

2025-07-11

Reason

Jefferies

Laurence Alexander

Price Target

$63 -> $66

2025-07-11

downgrade

Buy

Hold

Reason

Jefferies analyst Laurence Alexander downgraded Nutrien to Hold from Buy with a price target of $66, up from $63. The firm says the shares have benefited year-to-date from multiple disruptions in fertilizer supply. Nutrien's positive earnings momentum in the near-term now appears discounted in the shares, while consensus revisions are likely to peak by mid-2026, the analyst tells investors in a research note. By 2027, Jefferies expect the focus to shift to "supply shocks" for nitrogen and potash and margin pressure for nitrogen, creating "risks on the horizon" for Nutrien.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Nutrien Ltd (NTR.N) is 12.89, compared to its 5-year average forward P/E of 11.72. For a more detailed relative valuation and DCF analysis to assess Nutrien Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

11.72

Current PE

12.89

Overvalued PE

15.97

Undervalued PE

7.47

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

6.60

Current EV/EBITDA

7.13

Overvalued EV/EBITDA

8.03

Undervalued EV/EBITDA

5.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.14

Current PS

1.09

Overvalued PS

1.30

Undervalued PS

0.98